Medical Xpress news
Medical Xpress / Hormone therapy may not benefit most men receiving radiotherapy after prostate surgery, study finds
A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that adding hormone therapy to postoperative radiotherapy may provide little survival benefit for most men with prostate cancer, especially ...
Medical Xpress / New study maps what we do and don't know about outcomes for children in care
A new study led by Swansea University has mapped international evidence on the outcomes of children who grow up in out-of-home care. Drawing on 77 reviews, published between January 2013 and July 2024, research, shows which ...
Medical Xpress / New GLP-1 pill orforglipron outperforms oral semaglutide in yearlong diabetes trial
A novel GLP-1 receptor agonist (RA) pill called orforglipron leads to a larger reduction in blood sugar levels after a year than the current available oral GLP-1 RA (semaglutide), finds a phase 3 randomized controlled trial ...
Medical Xpress / Rapid iron flux test could help improve cartilage repair through cell therapy
Researchers from the Critical Analytics for Manufacturing Personalized Medicine (CAMP), an interdisciplinary research group (IRG) of Singapore-MIT Alliance for Research and Technology (SMART), in collaboration with Massachusetts ...
Medical Xpress / After the heart stops: Circulatory-death donors now supply nearly half of organs
Organ donation after the heart stops beating, a practice called donation after circulatory death, has gone from rare to routine in the United States, a new study shows. This shift over the past 25 years, aided by technological ...
Medical Xpress / Music may not boost focus or mood during exercise
Music is commonly used during exercise and is often assumed to improve focus, mood, or mental performance. A new systematic review and meta-analysis led by researchers at the Centre of Excellence in Music, Mind, Body and ...
Medical Xpress / Oral semaglutide found to lower risk of heart failure events in people with type 2 diabetes
An international clinical trial has found that an oral form of semaglutide, a widely used diabetes drug, reduced the risk of serious heart failure events in people with type 2 diabetes who already had heart failure. The findings, ...
Medical Xpress / Financial strain of cancer treatment undermines hope and life satisfaction new study finds
Cancer treatment can take a profound financial toll, and new research shows the damage does not stop at the bank account. Nearly half of patients experience significant "financial toxicity," and that strain quietly chips ...
Medical Xpress / Tackling tuberculosis systematically: How the environment shapes TB risk
Despite major advances in diagnostics and treatment, tuberculosis (TB) remains the world's deadliest infectious disease. In a new study published in The Lancet Global Health, researchers from Ludwig Maximilian University ...
Medical Xpress / Dry eye often precedes autoimmune disease diagnosis, new study finds
Frequent dry eyes may signal more than simple irritation and could be an early warning sign of an autoimmune disease. This symptom has long been associated with Sjögren's Disease, a chronic autoimmune condition in which ...
Medical Xpress / Frequently distracted? Your brain rhythms may be to blame
Scientists may have new answers to why pop-ups or notifications grab our attention. Turns out our attention is on a cycle, shifting seven to 10 times per second. This rhythmic occurrence may be crucial for survival, as it ...
Medical Xpress / Scientists sharpen genetic maps to help pinpoint DNA changes that influence human health traits and disease risk
Scientists have identified how specific genetic changes function in cells to influence disease risk and other human health traits. By probing regions of DNA previously linked to disease, the work has created high-resolution ...
